Financhill
Back

Catalyst Pharmaceuticals, Inc. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Catalyst Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 24.59 Sell
20-day SMA: 23.87 Buy
50-day SMA: 23.6 Buy
200-day SMA: 22.28 Buy
8-day EMA: 20.35 Buy
20-day EMA: 12.4 Buy
50-day EMA: 6.02 Buy
200-day EMA: 1.67 Buy

Catalyst Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.71 Buy
Relative Strength Index (14 RSI): 54.59 Buy
Chaikin Money Flow: 691464 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.81 - 24.51) Buy
Bollinger Bands (100): (20.74 - 23.88) Buy

Catalyst Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Catalyst Pharmaceuticals, Inc. Stock

Is Catalyst Pharmaceuticals, Inc. Stock a Buy?

CPRX Technical Analysis vs Fundamental Analysis

Buy
66
Catalyst Pharmaceuticals, Inc. (CPRX) is a Buy

Is Catalyst Pharmaceuticals, Inc. a Buy or a Sell?

Catalyst Pharmaceuticals, Inc. Stock Info

Market Cap:
3B
Price in USD:
24.44
Share Volume:
1M

Catalyst Pharmaceuticals, Inc. 52-Week Range

52-Week High:
26.58
52-Week Low:
19.05
Buy
66
Catalyst Pharmaceuticals, Inc. (CPRX) is a Buy

Catalyst Pharmaceuticals, Inc. Share Price Forecast

Is Catalyst Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Catalyst Pharmaceuticals, Inc.

Is Catalyst Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.03 per share.

Technical Analysis of Catalyst Pharmaceuticals, Inc.

Should I short Catalyst Pharmaceuticals, Inc. stock?

* Catalyst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.